First, to monitor the effects of GANT, AFA and AFA + GANT treatments after 24 h on MM cells, basal levels of the Hh pathway activity were evaluated by evaluating  GLI1, GLI2, and Ptch1 mRNA levels in untreated MM cells. The gene discussed is GLI1; the disease is Miyoshi myopathy.